Data by Industry within the Healthcare Sector
|
| |
Marketcap |
Revenues (TTM) |
Net Income (TTM) |
Employees |
| Industry |
(Millions) |
(Millions) |
(Millions) |
Number |
| Biotechnology & Pharmaceuticals Industry |
$ 570,369 |
$ 100,101 |
$ -4,915 |
95,936 |
| Healthcare Facilities Industry |
$ 227,792 |
$ 236,412 |
$ 10,517 |
1,321,993 |
| Major Pharmaceutical Preparations Industry |
$ 4,079,113 |
$ 757,084 |
$ 73,396 |
1,235,994 |
| Medical Equipment & Supplies Industry |
$ 1,280,570 |
$ 307,386 |
$ 19,819 |
864,819 |
| Medical Laboratories Industry |
$ 242,814 |
$ 117,095 |
$ -168 |
450,191 |
| Laboratory Analytical Instruments Industry |
$ 135,491 |
$ 31,142 |
$ -1,084 |
100,082 |
| In Vitro & In Vivo Diagnostic Substances Industry |
$ 56,707 |
$ 10,425 |
$ -748 |
21,491 |
| Total Healthcare Sector |
$ 6,592,856 |
$ 1,559,645 |
$ 96,818 |
4,090,506 |
Recent News from Healthcare Sector |
|
Partnership
'Abstract'In an era where the pharmaceutical landscape is rapidly evolving, the integration of artificial intelligence (AI) and machine learning into drug development processes has emerged as a pivotal factor in enhancing efficiency and outcomes. This article discusses the groundbreaking strategic collaboration between BullFrog AI and Sygnature Discovery,...
|
|
|
Clinical Study
'Abstract' Third Harmonic Bio Inc. (THB) has recently undergone significant corporate transformations, including stockholder-approved liquidation and dissolution. Meanwhile, financial ratios reveal a dynamic yet challenging fiscal environment. This article explores the implications of these developments for the company and its stakeholders, providing ins...
|
|
|
Product Service News
NewGen's Strategic US$45 Million Investment: A Boon for the UAE Real Estate MarketNewGenIVF Group Limited (NASDAQ: NIVF), a prominent player in the investment landscape, has announced a strategic investment of US$45 million into the vibrant real estate market of the United Arab Emirates (UAE). This move signals the company's intent to capitalize on burge...
|
|
|
Announcement
'MAINZ and TÜBINGEN, Germany, June 12, 2025' ?? In a groundbreaking development within the global biotechnology landscape, BioNTech SE (Nasdaq: BNTX) and CureVac N.V. (Nasdaq: CVAC) have jointly announced a strategic agreement, wherein BioNTech intends to acquire CureVac in an all-stock transaction. This acquisition marks a significant milestone as both c...
|
|
|
Clinical Study
In a significant stride for the field of nuclear medicine, Lantheus Holdings, Inc., a leading radiopharmaceutical company, has announced the presentation of promising new data at the upcoming 2025 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting. Scheduled for June 21-24 in New Orleans, Louisiana, this year's meeting highlights Lan...
|
|
|
Business Update
In a groundbreaking development for oncology therapeutics, BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235) announced that the U.S. Food and Drug Administration (FDA) has approved a new tablet formulation of BRUKINSA (zanubrutinib) for all five previously sanctioned indications. Originally introduced to combat chronic lymphocytic leukemia (CLL...
|
|
|
Announcement
Allarity Therapeutics, Inc. (NASDAQ: ALLR), a pharmaceutical company focused on advancing personalized cancer therapies, has announced a significant change in its Board of Directors. Effective June 30, 2025, Jesper Hiland will be appointed to the board, taking the position previously held by Joseph Vazzano, who will step down after serving for two years.A...
|
|
|
Clinical Study
Breakthrough Developments in Lupus and Kidney Transplant Treatments: Dapirolizumab Pegol and Felzartamab Lead the WayIn recent pivotal advancements within the field of immunology, Biogen Inc. (NASDAQ: BIIB) and UCB (Euronext Brussels: UCB) have demonstrated significant progress in the treatment of challenging conditions such as systemic lupus erythematos...
|
|
|
Announcement
'Organon Shareholder Alert: Investors Urged to Act Amid Class Action Lawsuit Due to Underperformance'In a noteworthy development for shareholders of Organon and Co. (NYSE: OGN), ClaimsFiler has issued a reminder to investors who have suffered losses exceeding $100,000 to file lead plaintiff applications in an ongoing class action lawsuit. The deadline for...
|
|
|
Announcement
' for CSIMarket.com ''PepGen Inc.: Navigating a Strategic Pivot Amidst Legal and Market Challenges'PepGen Inc. (NASDAQ: PEPG), a biopharmaceutical company, currently finds itself at a crucial juncture. Recently, the law firm Bragar Eagel and Squire, P.C. announced a class action lawsuit against the company, urging investors to contact them for possible c...
|
|
|
Product Service News
Editas Medicine, a pioneering company in the field of gene editing, presented significant advancements in their proprietary targeted lipid nanoparticle (LNP) delivery system at the European Hematology Association (EHA) 2025 Congress held in June. The focus of their findings was on the in vivo editing of the HBG1/2 promoter, a critical target for treating...
|
|
|
Equity Market Information
The biotechnology landscape is continuously evolving, driven by scientific advancements and the growing demand for affordable therapies. A notable development in this sector is the recent private placement completed by Alvotech (NASDAQ: ALVO, ALVOSDB), a leading biopharmaceutical company known for its focus on biosimilar medicines. This significant finan...
|
|
|
Clinical Study
Capricor Therapeutics, a biotechnology company focused on developing innovative cell and exosome-based therapeutics for rare diseases, has announced significant regulatory progress for its Duchenne Muscular Dystrophy (DMD) program. The company reported the successful completion of a Pre-License Inspection (PLI) of its manufacturing facility located in San...
|
|
|
Business Update
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a biotechnology company renowned for its innovation in small molecule drugs targeting viral infections and immunological diseases, has recently secured a significant milestone. The U.S. Food and Drug Administration (FDA) has granted approval for an expanded indication for MAVYRET (glecaprevir/pibrentasvir), a p...
|
|
|
Business Update
In a significant development for pediatric healthcare, ENvue Medical, a division of NanoVibronix, Inc. (NASDAQ: NAOV), has secured a U.S. patent for its innovative Pediatric Feeding Tube Guidance System. The new patent, numbered 12,324,632 and titled Insertion Device Positioning Guidance System, represents a crucial enhancement to the company's intellectu...
|
|
|
Clinical Study
In an exciting development in the realm of mental health therapeutics, Silo Pharma, Inc. (Nasdaq: SILO) has made significant strides toward advancing its innovative PTSD treatment, SPC-15. Silo Pharma recently announced that the U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance for its U.S. Patent Application No. 17954,858, titled ...
|
|
|
Clinical Study
Osteoarthritis (OA) is a progressive degenerative disease characterized by the breakdown of cartilage and underlying bone, leading to significant pain and functional limitations. The potential for gene therapy to offer a durable solution for managing OA symptoms has garnered considerable attention. This review presents findings from the recent unveiling ...
|
|
|
Partnership
In today?s evolving healthcare landscape, women's health, particularly in reproductive medicine, has emerged as a focal point of innovation and investment. Femasys, Inc. a prominent player in this sector, has recently bolstered its standing through a forward-thinking partnership with the Carolinas Fertility Institute (CFI), one of America's premier fertil...
|
|
|
Business Update
In a significant move to enhance its market presence and address the needs of patients with rare blood clotting disorders, Agios Pharmaceuticals Inc. (NASDAQ: AGIO) announced a strategic partnership with Avanzanite. This collaboration aims to facilitate the introduction of PYRUKYND, a key therapeutic product, across Europe. The initiative not only solidif...
|
|
|
Partnership
Revolutionizing Cellular Therapy: MaxCyte and Ori Biotech?s Game-Changing CollaborationIn the fast-paced world of biotechnological innovation, where the stakes are as high as the potential benefits, the partnership between MaxCyte and Ori Biotech emerges as a beacon of transformative potential. With the convergence of advanced platforms, cutting-edge tec...
|
|
|
Product Service News
In a forward-thinking move set to reshape the fantasy sports landscape, ECGI Holdings has announced its investment in Payday Fantasy, an AI-powered startup that promises to revolutionize the way sports enthusiasts engage with fantasy leagues. With the integration of cutting-edge artificial intelligence technology and a focus on social gameplay, Payday Fan...
|
|
|
Partnership
In a groundbreaking partnership, Progyny Inc. has become the first women?s health and family building solution to join Amazon's Health Benefits Connector Program. This collaboration promises to empower Amazon customers eligible for Progyny services by facilitating their access to vital fertility, family building, and menopause benefits. The initiative is ...
|
|
|
Announcement
In a significant advancement for cardiac care technology, Catheter Precision, Inc. a leader in innovative healthcare solutions, has announced a pivotal purchase order from the prestigious Sahlgrenska University Hospital (SUH) in Gothenburg, Sweden. As the largest hospital in the country and an eminent center for ventricular tachycardia (VT) treatment in S...
|
|
|
Clinical Study
Presented by CSIMarket.com In a groundbreaking presentation at the BBA 2025, AVITA Medical showcased the largest real-world analysis of its RECELL system, highlighting its potential to revolutionize inpatient burn care. Combining technological innovation with economic impact offers encouraging results for healthcare providers and patients alike. This a...
|
|
|
Business Update
In a significant move for home care services, Addus HomeCare Corporation (Nasdaq: ADUS), a leading provider in the sector, has welcomed the recent state legislature budget approvals that will enhance reimbursement rates for in-home care in Illinois and Texas. This development not only marks a crucial step forward in addressing the pressing need for qualit...
|
|
|
Business Update
Expanding Horizons in Rare Blood Disorders: Avanzanite and Agios Pharmaceuticals Forge a Strategic Alliance for PYRUKYND Launch The landscape of rare blood disorder treatment is experiencing a significant shift with the recent announcement of a strategic partnership between Avanzanite Bioscience B.V. and Agios Pharmaceuticals, Inc. This collaboration set...
|
|
|
Business Update
In a significant breakthrough in the fight against early-stage breast cancer, Guardant Health, Inc. has announced promising results from its recent LIBERATE study, published in the esteemed journal ESMO Open. The study highlights the performance of Guardant Reveal, a minimal residual disease (MRD) blood test that employs advanced epigenomic (methylation) ...
|
|
|
Business Update
Butterfly Network's Lead Exemption Faces EU Scrutiny Amidst Industry Acclaim and Strategic EngagementsBurlington, Mass. and New York - Butterfly Network, Inc. (NYSE: BFLY), a leading player in digital health innovation with its handheld, whole-body ultrasound technology, is currently navigating a key regulatory and strategic phase. The company recently ...
|
|
|
Announcement
This article examines the ongoing investigation led by Pomerantz Law Firm into claims on behalf of investors of Summit Therapeutics Inc. (NASDAQ: SMMT). As the company faces scrutiny, the implications of investor confidence and corporate governance are explored, particularly in light of the company?s financial performance and revenue generation. In the...
|
|
|
Product Service News
Gastroesophageal reflux disease (GERD) is a chronic condition characterized by the backflow of stomach contents into the esophagus, causing symptoms such as heartburn, chest pain, and regurgitation. Among its various forms, Erosive GERD (EGD), which leads to inflammation and damage of the esophageal lining, poses significant treatment challenges. The intr...
|
|
|
|
|
|
